References
- Afkhami-Ardekani M, Kamali-Aredekani AR, Shojaoddiny-Ardekani A. Effect of garlic on serum lipids and blood glucose of type 2 diabetic patients. Int J Diab Dev Ctries. 2006;26(2):86–88.
- Agarwal KC. Therapeutic action of garlic constituent. Med Res Rev. 1996;16(1):111–124.
- Augusti KT. Therapeutic value of onion (Allium cepa L.) and garlic (Allium sativum L.). Indian J Exp Bio. 1996;34(7):634–640.
- Bakhsh R, Chughtai MI. Influence of garlic on serum cholesterol, serum triglycerides, serum total lipids and serum glucose in human subject. Nahrung. 1984;28(2):159–163.
- Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: a review. Nutr J. 2002;1(4):1–14.
- Berthold HK, Sudhop T, Von Bergmann K. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized control trial. JAMA. 1998;279:1900–1902.
- Bordia A. Effect of garlic on blood lipids in patients with coronary heart disease. Am J Clin Nutr. 1981;34(10):2100–2103.
- Campbell JH, Efendy JL, Smith NJ, Campbell GR. Molecular basis by which garlic suppresses atherosclerosis. J Nut. 2001;131(3s):1006s–1009s.
- Choudhary PR, Jani RD. Study of pulmonary function in patients with metabolic syndrome. Iranian J Physiol Pharmacol. 2016a;20:90–97.
- Choudhary PR, Jani RD. Study of thyroid function in patients with metabolic syndrome. Int J Res Med Sci. 2016b;4(6):2024–2029.
- Choudhary PR, Shekhawat JS, Sharma MS, Dashora J. Effect of Allium sativum on experimentally induced hyperlipidemia in guinea pigs. Pak J Physiol. 2013;9(2):38–40.
- Cleeman JI. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–2497.
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
- Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol. 2006;47:1093–1100.
- Jain AK, Vargas R, Gotzkowsky S, McMahon FG. Can garlic reduce levels of serum lipid? A controlled clinical study. Am J Med. 1993;94:632–635.
- Jain RC. Onion and garlic in experimental induced atherosclerosis. Ind J Med Res. 1976;76:1508–1515.
- Kylin E. Studien ueber das Hypertonie-Hyperglyka “mie-Hyperurika” miesyndrom. Zentralblatt fuer Innere Medizin. 1923;44:105–127.
- Lau BHS, Lam F, Wang-Cheng R. Effect of an odor modified garlic preparation on blood lipid. Nut Res. 1987;7:139–149.
- Mansell P, Salisbury UK, Reckless JP. The effect of dried garlic powder tablets on serum lipids in non insulin dependent diabetic patients. Am J Clin Nutr. 2002;66:261–266.
- Qureshi AA, Din ZZ, Abuirmeileh N. Suppression of avian hepatic lipid metabolism by solvent extract of garlic: impact on serum lipid. J. Nutr. 1983;113:1746–1755.
- Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607.
- Ried K, Frank OR, Stocks NP, Fakler P, Sullivan T. Effect of garlic on blood pressure: a systematic review and meta-analysis. BMC Cardiovasc Dis. 2008;8:1–13.
- Superko HR, Krauss RM. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanism. New Engl J Med. 2000;322:512–521.
- Tkac I. Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis. Diabetes Res Clin Pract. 2005;68(suppl):S2–S9.
- World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization; 1999.
- Zhang XH, Lowe D, Giles P, Fell S, Board AR, Baughan JA, et al. A randomized trial of the effects of garlic oil upon coronary heart disease risk factors in trained male runners. Blood Coagul Fibrinolysis. 2001;12:67–74.